您的位置: 首页 > 农业专利 > 详情页

THERAPEUTIC ANTIBODIES
专利权人:
Novo Nordisk A/S
发明人:
ZAHN, Stefan,ZEUTHEN, Louise Hjerrild,HANSEN, Anker Jon,KJÆRGAARD, Kristian,LUND, Søren
申请号:
DK12725447
公开号:
DK2718322T3
申请日:
2012.06.04
申请国别(地区):
DK
年份:
2018
代理人:
摘要:
The present invention concerns human antibodies recognizing the human C5a receptor. By binding to C5aR the antibodies inhibit C5a signaling, whereby the pro- inflammatory signal is inhibited. Based on the role of C5a and its receptor in stimulation of inflammation the invention further relates to therapeutic use of said human anti-C5aR antibodies and in particular in relation to treatment of immunological disorders.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充